Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8500297rdf:typepubmed:Citationlld:pubmed
pubmed-article:8500297lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8500297lifeskim:mentionsumls-concept:C0012265lld:lifeskim
pubmed-article:8500297lifeskim:mentionsumls-concept:C1522565lld:lifeskim
pubmed-article:8500297lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:8500297lifeskim:mentionsumls-concept:C0242973lld:lifeskim
pubmed-article:8500297lifeskim:mentionsumls-concept:C0012000lld:lifeskim
pubmed-article:8500297lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8500297lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8500297pubmed:issue2lld:pubmed
pubmed-article:8500297pubmed:dateCreated1993-7-1lld:pubmed
pubmed-article:8500297pubmed:abstractText34 patients with ventricular dysfunction (18 in NYHA class II and 16 in NYHA class III heart failure) whose clinical status was stabilized by diuretics and systemic vasodilators, entered a randomized trial to compare the effects of short-term oral digoxin and active placebo on left ventricular diastolic function, non invasively evaluated by echo-Doppler transmitral left ventricular filling flow. At baseline patients were subdivided by reversal--the ratio of peak early (E) and late (A) transmitral filling velocities--E/A < 1 (group I) or normal--E/A > or = 1 (group II) echo-Doppler E/A ratio; group II exhibited a shorter deceleration time (125 +/- 20 ms vs 198 +/- 38 ms, p > 0.05) and isovolumic relaxation time (64 +/- 15 ms vs 93 +/- 10 ms; p < 0.05) as well as a higher peak E velocity (85 +/- 28 cm/s vs 54 +/- 20 cm/s; p < 0.05), ("restrictive" left ventricular filling pattern). After 4 weeks, no changes in all echo-Doppler parameters were noted in group I in response to either oral digoxin or active placebo. Clinical amelioration (defined as reduction by at least one functional class) was observed in 3 patients after digoxin.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:8500297pubmed:languageenglld:pubmed
pubmed-article:8500297pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8500297pubmed:citationSubsetIMlld:pubmed
pubmed-article:8500297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8500297pubmed:statusMEDLINElld:pubmed
pubmed-article:8500297pubmed:issn0010-8650lld:pubmed
pubmed-article:8500297pubmed:authorpubmed-author:AdinolfiLLlld:pubmed
pubmed-article:8500297pubmed:authorpubmed-author:MaioneSSlld:pubmed
pubmed-article:8500297pubmed:authorpubmed-author:GiuntaAAlld:pubmed
pubmed-article:8500297pubmed:authorpubmed-author:PalmaMMlld:pubmed
pubmed-article:8500297pubmed:authorpubmed-author:GiacummoAAlld:pubmed
pubmed-article:8500297pubmed:authorpubmed-author:LosardoLLlld:pubmed
pubmed-article:8500297pubmed:authorpubmed-author:ArneseMMlld:pubmed
pubmed-article:8500297pubmed:issnTypePrintlld:pubmed
pubmed-article:8500297pubmed:volume35lld:pubmed
pubmed-article:8500297pubmed:ownerNLMlld:pubmed
pubmed-article:8500297pubmed:authorsCompleteYlld:pubmed
pubmed-article:8500297pubmed:pagination57-63lld:pubmed
pubmed-article:8500297pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:meshHeadingpubmed-meshheading:8500297-...lld:pubmed
pubmed-article:8500297pubmed:year1993lld:pubmed
pubmed-article:8500297pubmed:articleTitleEffects of short-term oral digoxin on left ventricular diastolic filling in patients with ventricular dysfunction. An echo-Doppler study.lld:pubmed
pubmed-article:8500297pubmed:affiliationInstitute of Clinical Medicine I, 2nd Faculty of Medicine, University of Naples, Italy.lld:pubmed
pubmed-article:8500297pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8500297pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8500297pubmed:publicationTypeRandomized Controlled Triallld:pubmed